Geographic Atrophy in Age-related Macular Degeneration

Inbunden, Engelska, 2026

1 934 kr

Kommande

Beskrivning

Geographic Atrophy in Age-related Macular Degeneration provides a comprehensive resource on this flourishing discipline, focusing on accurate diagnosis, imaging features, clinical trials, differential diagnoses, and both established and emerging treatment options. The book details diagnostic processes using techniques such as visual acuity tests, dilated eye exams, fundus photography, optical coherence tomography (OCT), and fluorescein angiography, emphasizing the importance of early detection. It also differentiates geographic atrophy from other retinal conditions with similar symptoms, such as dystrophies, equipping practitioners with the knowledge for accurate diagnosis.

Additionally, it explores traditional management approaches like antioxidant supplements, lifestyle changes, and low vision aids, alongside novel treatments such as complement inhibitors, cell-based therapies, and gene therapy, to inform clinicians about the latest advancements and research in patient care. With the recent FDA approval for GA treatment, there has been significant interest in the retina community. This rapidly growing field necessitates a new book on geographic atrophy in age-related macular degeneration to address gaps in existing literature and provide up-to-date, comprehensive information.

Provides up-to-date knowledge, consolidating the latest advancements and established knowledge in the diagnosis, differential diagnoses, and treatment of geographic atrophy in age-related macular degeneration
Acts as a comprehensive resource, providing a thorough and integrated overview of available data, making it an essential guide for clinicians, researchers, and anyone seeking a deep understanding of GA in AMD
Offers practical insights, guidance, and actionable information for both medical professionals and patients, thus enhancing patient care and supporting informed decision-making

Produktinformation

Utgivningsdatum:2026-10-15
Mått:191 x 235 x undefined mm
Vikt:450 g
Format:Inbunden
Språk:Engelska
Antal sidor:400
Förlag:Elsevier Science
ISBN:9780443445774

Utforska kategorier

Biologi inom Naturvetenskap och teknik

Mer om författaren

Jay Chhablani MD is Professor of Ophthalmology and vitreo-retina surgeon at the University of Pittsburgh Eye Center, USA. He established the “Choroid Analysis and Research (CAR) Lab, which focuses on computational as well as biological research in the field of choroid. He has published more than 650 articles in peer-reviewed journals with a focus in the field of choroid. He is the editor of books “Choroidal Disorders, “Central Serous Chorioretinopathy and “Choroidal Neovascularization. He is on the editorial board of several journals, including the American Journal of Ophthalmology. He has won several national and international awards and delivered named lectures. As a board-certified ophthalmologist, Caroline R. Baumal MD, FASRS has authored over 170 publications and has been recognized with numerous prestigious awards, including the Senior Achievement Award from the American Academy of Ophthalmology, the Crystal Apple Award from the American Society of Retina Specialists, and the Lifetime Achievement Award from the Vit-Buckle Society. She also has been involved with research and clinical trials investigating novel therapies for retinal diseases. Caroline studied biochemistry at McGill University and received an MD from the University of Toronto, where she also completed her ophthalmology residency followed by two fellowships: Retinal Surgery at Wills Eye Hospital and Medical Retinal and Lasers at New England Eye Center.

Innehållsförteckning

1. Definitions2. Histopathology and mechanisms3. Epidemiology and risk factors including genetics4. Non-dye-based imaging, Fundus photo, IR, FAF5. OCT6. OCTA7. Dye-based imaging (FA, ICG)8. Visual Function test (electrophysiology, dark adaptation, etc)9. Differential diagnosis and masquerades10. GA progression11. GA association with CNV12. Role of AI in diagnosis and follow-up13. GA management (prevention, old treatments, new treatments with side effects, Visual cycle modulators, mTOR inhibitors, complement inhibitors, MMP inhibitors, LDL lowering drugs, Anti-amyloid beta, Antioxidants and neuroprotectants; Choroidal perfusion enhancers14. GA management (Surgical approaches)15. Failed approaches in GA16. Learnings from GA clinical trials17. Burden of disease, visual rehabilitation, Psychosocial Impact18. Personalized medicine in GA: The future is here